Correlation Between Qiagen NV and ProPhase Labs
Can any of the company-specific risk be diversified away by investing in both Qiagen NV and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qiagen NV and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qiagen NV and ProPhase Labs, you can compare the effects of market volatilities on Qiagen NV and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qiagen NV with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qiagen NV and ProPhase Labs.
Diversification Opportunities for Qiagen NV and ProPhase Labs
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Qiagen and ProPhase is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Qiagen NV and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Qiagen NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qiagen NV are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Qiagen NV i.e., Qiagen NV and ProPhase Labs go up and down completely randomly.
Pair Corralation between Qiagen NV and ProPhase Labs
Given the investment horizon of 90 days Qiagen NV is expected to under-perform the ProPhase Labs. But the stock apears to be less risky and, when comparing its historical volatility, Qiagen NV is 8.16 times less risky than ProPhase Labs. The stock trades about -0.13 of its potential returns per unit of risk. The ProPhase Labs is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 72.00 in ProPhase Labs on December 28, 2024 and sell it today you would lose (26.00) from holding ProPhase Labs or give up 36.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Qiagen NV vs. ProPhase Labs
Performance |
Timeline |
Qiagen NV |
ProPhase Labs |
Qiagen NV and ProPhase Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Qiagen NV and ProPhase Labs
The main advantage of trading using opposite Qiagen NV and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qiagen NV position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.Qiagen NV vs. Neogen | Qiagen NV vs. Aclaris Therapeutics | Qiagen NV vs. IQVIA Holdings | Qiagen NV vs. Medpace Holdings |
ProPhase Labs vs. Star Equity Holdings | ProPhase Labs vs. Enzo Biochem | ProPhase Labs vs. Neuronetics | ProPhase Labs vs. Intelligent Bio Solutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Valuation Check real value of public entities based on technical and fundamental data |